Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA, Mitochondrial | 9 | 2021 | 165 | 1.760 |
Why?
|
| DNA Damage | 11 | 2021 | 341 | 1.670 |
Why?
|
| Huntington Disease | 5 | 2016 | 25 | 1.200 |
Why?
|
| Mitochondria | 6 | 2021 | 454 | 1.070 |
Why?
|
| Oxidative Stress | 8 | 2016 | 874 | 0.840 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2014 | 224 | 0.650 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 2017 | 16 | 0.590 |
Why?
|
| DNA Repair | 5 | 2021 | 181 | 0.530 |
Why?
|
| Cyclic N-Oxides | 4 | 2016 | 17 | 0.520 |
Why?
|
| Hydroxycholesterols | 4 | 1999 | 12 | 0.500 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 151 | 0.450 |
Why?
|
| Neostriatum | 1 | 2012 | 25 | 0.440 |
Why?
|
| Mitochondria, Liver | 1 | 2011 | 15 | 0.420 |
Why?
|
| Apoptosis | 5 | 2000 | 1317 | 0.350 |
Why?
|
| Aging | 1 | 2011 | 639 | 0.290 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 430 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 1999 | 968 | 0.230 |
Why?
|
| Sterols | 2 | 1999 | 22 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 1999 | 52 | 0.210 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 49 | 0.210 |
Why?
|
| Motor Activity | 2 | 2016 | 393 | 0.210 |
Why?
|
| Cholesterol | 2 | 2000 | 194 | 0.200 |
Why?
|
| Animals | 13 | 2021 | 14307 | 0.190 |
Why?
|
| Genes, myc | 2 | 2000 | 28 | 0.180 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2019 | 6 | 0.180 |
Why?
|
| Electron Transport | 1 | 2019 | 38 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 1300 | 0.170 |
Why?
|
| Housing, Animal | 1 | 2018 | 11 | 0.170 |
Why?
|
| Mitochondria, Heart | 2 | 2019 | 66 | 0.160 |
Why?
|
| Sunlight | 1 | 2018 | 46 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2016 | 351 | 0.160 |
Why?
|
| Time Factors | 3 | 2014 | 1681 | 0.150 |
Why?
|
| Down-Regulation | 1 | 1999 | 420 | 0.150 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2016 | 17 | 0.140 |
Why?
|
| Glutathione Reductase | 1 | 2016 | 22 | 0.140 |
Why?
|
| Mice | 6 | 2019 | 5668 | 0.140 |
Why?
|
| Vitamin D | 1 | 2018 | 176 | 0.140 |
Why?
|
| Macaca mulatta | 2 | 2018 | 122 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 406 | 0.140 |
Why?
|
| Plasmodium berghei | 1 | 2016 | 29 | 0.140 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 3 | 0.140 |
Why?
|
| Humans | 14 | 2021 | 34853 | 0.140 |
Why?
|
| Malaria | 1 | 2016 | 68 | 0.130 |
Why?
|
| Glutathione | 1 | 2016 | 160 | 0.130 |
Why?
|
| Hydrogen Peroxide | 2 | 2014 | 181 | 0.130 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 35 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 65 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 416 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 1994 | 25 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 5 | 2000 | 480 | 0.120 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 72 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 1999 | 1152 | 0.120 |
Why?
|
| Lymphocytes | 1 | 1994 | 116 | 0.120 |
Why?
|
| Antioxidants | 2 | 2016 | 386 | 0.110 |
Why?
|
| Male | 8 | 2019 | 18870 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 106 | 0.110 |
Why?
|
| Autopsy | 1 | 2012 | 40 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 1994 | 145 | 0.110 |
Why?
|
| Protein Carbonylation | 1 | 2011 | 8 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 1997 | 37 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 608 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2013 | 160 | 0.100 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2011 | 12 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 413 | 0.100 |
Why?
|
| Catalase | 1 | 2011 | 106 | 0.100 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 109 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 131 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1056 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 407 | 0.100 |
Why?
|
| Cell Survival | 4 | 2012 | 818 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2012 | 252 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 1994 | 522 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 338 | 0.090 |
Why?
|
| DNA, Neoplasm | 3 | 1998 | 86 | 0.090 |
Why?
|
| DNA Fragmentation | 3 | 2000 | 91 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 639 | 0.090 |
Why?
|
| Liver | 1 | 2011 | 447 | 0.090 |
Why?
|
| Glucocorticoids | 2 | 1999 | 80 | 0.080 |
Why?
|
| Mutation | 1 | 2012 | 1023 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2019 | 71 | 0.080 |
Why?
|
| Carcinogens | 2 | 2017 | 117 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2000 | 550 | 0.070 |
Why?
|
| Receptors, Steroid | 2 | 1999 | 33 | 0.070 |
Why?
|
| DNA | 2 | 2000 | 549 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2561 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 1530 | 0.070 |
Why?
|
| Cell Line | 3 | 2019 | 1289 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 984 | 0.060 |
Why?
|
| Cell Division | 3 | 2000 | 296 | 0.060 |
Why?
|
| Weight Loss | 2 | 2016 | 124 | 0.060 |
Why?
|
| Middle Aged | 2 | 2014 | 9642 | 0.060 |
Why?
|
| Rats | 2 | 2019 | 3261 | 0.060 |
Why?
|
| Female | 3 | 2015 | 19873 | 0.050 |
Why?
|
| Methyl Methanesulfonate | 1 | 2000 | 6 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 27 | 0.050 |
Why?
|
| Alkylating Agents | 1 | 2000 | 13 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2000 | 66 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 89 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 119 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1442 | 0.050 |
Why?
|
| Magnesium | 1 | 2000 | 95 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 20 | 0.050 |
Why?
|
| Kinetics | 2 | 2000 | 650 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 275 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 38 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 1 | 1999 | 4 | 0.040 |
Why?
|
| Half-Life | 1 | 1999 | 52 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 161 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1999 | 26 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 210 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 139 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 51 | 0.040 |
Why?
|
| Adult | 1 | 2014 | 11034 | 0.040 |
Why?
|
| Caspases | 1 | 1999 | 132 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1999 | 125 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2018 | 63 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 65 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 7 | 0.040 |
Why?
|
| Caspase 1 | 1 | 1997 | 15 | 0.040 |
Why?
|
| Clone Cells | 1 | 1997 | 46 | 0.040 |
Why?
|
| Nucleosomes | 1 | 1997 | 27 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2000 | 436 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 165 | 0.040 |
Why?
|
| Azoxymethane | 1 | 2017 | 7 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 57 | 0.040 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 10 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 186 | 0.040 |
Why?
|
| Dexamethasone | 1 | 1997 | 43 | 0.040 |
Why?
|
| Neurons | 2 | 2016 | 1130 | 0.040 |
Why?
|
| Estradiol | 1 | 1998 | 244 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1999 | 834 | 0.040 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 27 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 46 | 0.030 |
Why?
|
| Protein Binding | 1 | 1999 | 913 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2016 | 43 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2015 | 16 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 608 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 98 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 109 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 228 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2014 | 89 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2016 | 304 | 0.030 |
Why?
|
| Cell Separation | 1 | 1994 | 91 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1994 | 93 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 580 | 0.030 |
Why?
|
| Cell Death | 1 | 1994 | 260 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2012 | 74 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2015 | 897 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 239 | 0.030 |
Why?
|
| Aged | 1 | 2014 | 6448 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 126 | 0.010 |
Why?
|
| Leukemia | 1 | 2000 | 54 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 18 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1998 | 53 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1998 | 39 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 44 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 52 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 217 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 445 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1998 | 81 | 0.010 |
Why?
|
| Kidney | 1 | 1998 | 322 | 0.010 |
Why?
|